UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 764

Sortiert nach

A Psychosocial Approach to Understanding Underground Spaces

Frontiers in psychology, 2017-03, Vol.8, p.452-452

2017

Volltextzugriff (PDF)

1343P Amivantimab as a salvage strategy post TKI (osimertinib/mobocertinib) in EGFRm NSCLC

Annals of oncology, 2023-10, Vol.34, p.S773-S773

2023

Volltextzugriff (PDF)

P76.57 Resistance Mechanisms to Osimertinib Upon it’s Line of Therapy in Patients with EGFR+ NSCLC and Beyond

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S612-S612

2021

Volltextzugriff (PDF)

EP12.01-76 Adding Amivantamab as a Salvage Strategy Post EGFR TKI (Osimertinib/Mobocertinib) in EGFRm+ NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S672-S673

2023

Volltextzugriff (PDF)

1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options

Annals of oncology, 2021-09, Vol.32, p.S1142-S1143

2021

Volltextzugriff (PDF)

EP03.03-04 Decoding the Immune Dysfunction of Cancer Cachexia in Lung Cancer Patients

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S444

2023

Volltextzugriff (PDF)

P47.10 Neoadjuvant Osimertinib in EGFR-Mutant Stage IIIA/B NSCLC - A Phase 2 Open-Label Pilot Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1100-S1100

2021

Volltextzugriff (PDF)

Performance of the holographic multivergence target in the subjective measurement of spherical refractive error and amplitude of accommodation of the human eye

Journal of the Optical Society of America. A, Optics, image science, and vision, 2007-10, Vol.24 (10), p.3037

2007

Volltextzugriff (PDF)

1173P Induction osimertinib in EGFR-mutant stage IIIA/B NSCLC

Annals of oncology, 2021-09, Vol.32, p.S941-S941

2021

Volltextzugriff (PDF)

951P Induction osimertinib followed by definitive sequential radiation therapy and/or surgery in unresectable EGFR-mutant stage III NSCLC: An open-label, single-arm, phase II study

Annals of oncology, 2022-09, Vol.33, p.S982-S983

2022

Volltextzugriff (PDF)

133TiP Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S115-S115

2023

Volltextzugriff (PDF)

1206P UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)

Annals of oncology, 2021-09, Vol.32, p.S961-S962

2021

Volltextzugriff (PDF)

EP08.02-047 The Impact of CGP on the Decision-making Process in ALK+ aNSCLC After Failure of 2nd/3rd-Generation ALK TKIs

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S419-S421

2022

Volltextzugriff (PDF)

EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S460

2022

Volltextzugriff (PDF)

Anodised porous Nb2O5 for photoreduction of Cr(VI)

Materials today : proceedings, 2019, Vol.17, p.1033-1039

2019

Volltextzugriff (PDF)

750. AAV-2 Vectors and Protease-Activated Receptors: A Potential Interface between Coagulation and Gene Transfer

Molecular therapy, 2004-05, Vol.9 (S1), p.S285-S285

2004

Volltextzugriff (PDF)

Formation of 1-dimensional (1D) and 3-dimensional (3D) ZnO nanostructures by oxidation and chemical methods

Materialwissenschaft und Werkstofftechnik, 2012-05, Vol.43 (5), p.457-460

2012

Volltextzugriff (PDF)

An evaluation of the significance of mouth and hand contamination for lead absorption in lead-acid battery workers

International archives of occupational and environmental health, 1993-01, Vol.64 (6), p.439-443

1993

Volltextzugriff (PDF)

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

Advanced materials (Weinheim), 2022-09, Vol.34 (35), p.e2202169-n/a

2022

Volltextzugriff (PDF)

S-2-hydroxyglutarate regulates CD8 + T-lymphocyte fate

Nature (London), 2016-12, Vol.540 (7632), p.236-241

2016

Volltextzugriff (PDF)

TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

Clinical cancer research, 2012-01, Vol.18 (1), p.290-300

2012

Volltextzugriff (PDF)

A bioreducible N-oxide-based probe for photoacoustic imaging of hypoxia

Nature communications, 2017-11, Vol.8 (1), p.1794-9, Article 1794

2017

Volltextzugriff (PDF)

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Volltextzugriff (PDF)

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

American journal of respiratory and critical care medicine, 2010-02, Vol.181 (4), p.315-323

2010

Volltextzugriff (PDF)

Comparison of Aortobifemoral Bypass and Endovascular Treatment for Chronic Infrarenal Abdominal Aortic Occlusion From the CHAOS (CHronic Abdominal Aortic Occlusion, ASian Multicenter) Registry

Journal of endovascular therapy, 2023-12, Vol.30 (6), p.828-837

2023

Volltextzugriff (PDF)

1 – 25 von 764

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(653)
Mit Volltextzugriff
(701)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(763)
Japanisch
(119)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A Psychosocial Approach to Understanding Underground Spaces

1343P Amivantimab as a salvage strategy post TKI (osimertinib/mobocertinib) in EGFRm NSCLC

P76.57 Resistance Mechanisms to Osimertinib Upon it’s Line of Therapy in Patients with EGFR+ NSCLC and Beyond

EP12.01-76 Adding Amivantamab as a Salvage Strategy Post EGFR TKI (Osimertinib/Mobocertinib) in EGFRm+ NSCLC

1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options

EP03.03-04 Decoding the Immune Dysfunction of Cancer Cachexia in Lung Cancer Patients

P47.10 Neoadjuvant Osimertinib in EGFR-Mutant Stage IIIA/B NSCLC - A Phase 2 Open-Label Pilot Study

Performance of the holographic multivergence target in the subjective measurement of spherical refractive error and amplitude of accommodation of the human eye

1173P Induction osimertinib in EGFR-mutant stage IIIA/B NSCLC

951P Induction osimertinib followed by definitive sequential radiation therapy and/or surgery in unresectable EGFR-mutant stage III NSCLC: An open-label, single-arm, phase II study

133TiP Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study

1206P UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)

EP08.02-047 The Impact of CGP on the Decision-making Process in ALK+ aNSCLC After Failure of 2nd/3rd-Generation ALK TKIs

EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)

Anodised porous Nb2O5 for photoreduction of Cr(VI)

750. AAV-2 Vectors and Protease-Activated Receptors: A Potential Interface between Coagulation and Gene Transfer

Formation of 1-dimensional (1D) and 3-dimensional (3D) ZnO nanostructures by oxidation and chemical methods

An evaluation of the significance of mouth and hand contamination for lead absorption in lead-acid battery workers

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

S-2-hydroxyglutarate regulates CD8 + T-lymphocyte fate

TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

A bioreducible N-oxide-based probe for photoacoustic imaging of hypoxia

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Comparison of Aortobifemoral Bypass and Endovascular Treatment for Chronic Infrarenal Abdominal Aortic Occlusion From the CHAOS (CHronic Abdominal Aortic Occlusion, ASian Multicenter) Registry

Suchergebnisse filtern